Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Targeted Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06881017
What this trial is testing

Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping

Who this might be right for
Gastric CancerHER2 + Gastric CancerCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction+1 more
China Medical University, China 140
Large-scale testing (Phase 3)Looking for participantsNCT05770102
What this trial is testing

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

Who this might be right for
MalignancyMalignant NeoplasmLymphoproliferative Disorders+7 more
Cancer Research UK 30
Not applicableLooking for participantsNCT05667948
What this trial is testing

Molecular Analysis and Treatment Options of Thymic Malignancies

Who this might be right for
Thymic Epithelial TumorThymic CarcinomaThymic Cancer
Shanghai Chest Hospital 500
Not applicableNot Yet RecruitingNCT07327515
What this trial is testing

PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors

Who this might be right for
Malignant Tumors
Li Min 90
Large-scale testing (Phase 3)Looking for participantsNCT05786716
What this trial is testing

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Who this might be right for
Haematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK 30
Not applicableLooking for participantsNCT02290522
What this trial is testing

Copenhagen Prospective Personalized Oncology (CoPPO)

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Ulrik Lassen 500
Testing effectiveness (Phase 2)UnknownNCT03696186
What this trial is testing

Selective Treatment According to Molecular Subtype of Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerProstate Cancer Metastatic
Tianjin Medical University Second Hospital 300
Not applicableUnknownNCT03792529
What this trial is testing

Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in China

Who this might be right for
Breast Cancer
Peking University Cancer Hospital & Institute 300
Large-scale testing (Phase 3)Looking for participantsNCT05768178
What this trial is testing

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

Who this might be right for
Haematological MalignancyMelanomaThyroid Cancer, Papillary+9 more
Cancer Research UK 30
Not applicableStudy completedNCT01052532
What this trial is testing

Molecular Mechanisms of Mitral Regurgitation-Aim 2

Who this might be right for
Mitral Regurgitation
University of Alabama at Birmingham 65
Not applicableActive Not RecruitingNCT04931329
What this trial is testing

Onco-haematology Vigilance Card

Who this might be right for
Medical OncologyHematologyMolecular Targeted Therapies
University Hospital, Limoges 100
Not applicableUnknownNCT05177666
What this trial is testing

A Prospective Registration Study for Patients With Advanced Refractory Solid Tumors

Who this might be right for
FeasibilityEffectivenessSafety+1 more
The University of Hong Kong-Shenzhen Hospital 120
Testing effectiveness (Phase 2)Study completedNCT01306045
What this trial is testing

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Small Cell LungCarcinoma, Thymic
National Cancer Institute (NCI) 647
Testing effectiveness (Phase 2)UnknownNCT03182634
What this trial is testing

The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial

Who this might be right for
Advanced Breast Cancer
Institute of Cancer Research, United Kingdom 1,150
Early research (Phase 1)Looking for participantsNCT06253871
What this trial is testing

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Who this might be right for
HER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more
Iambic Therapeutics, Inc 383
Not applicableStudy completedNCT00896766
What this trial is testing

Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 150
Testing effectiveness (Phase 2)Study completedNCT00098254
What this trial is testing

BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
National Cancer Institute (NCI) 37
Early research (Phase 1)Ended earlyNCT02476955
What this trial is testing

Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

Who this might be right for
Solid TumorsOvarian CancerEndometrial Cancer
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 41
Not applicableStudy completedNCT05923268
What this trial is testing

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

Who this might be right for
Breast Cancer Female
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Testing effectiveness (Phase 2)Ended earlyNCT04585815
What this trial is testing

Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 34
Next Page